» Articles » PMID: 27665051

Glucagon-secretion Inhibition Using Somatostatin: An Old Hormone for the Treatment of Diabetes-associated Pancreatectomy

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2016 Sep 26
PMID 27665051
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pancreatic necrosis and severity are independent risk factors for pancreatic endocrine insufficiency after acute pancreatitis: A long-term follow-up study.

Yu B, Li N, He W, He C, Wan J, Zhu Y World J Gastroenterol. 2020; 26(23):3260-3270.

PMID: 32684740 PMC: 7336320. DOI: 10.3748/wjg.v26.i23.3260.


Bypassed and Preserved Stomach Resulted in Superior Glucose Control in Sprague-Dawley Rats with Streptozotocin-Induced Diabetes.

Widjaja J, Dolo P, Zhang Q, Yao L, Li C, Hong J Sci Rep. 2019; 9(1):9981.

PMID: 31292518 PMC: 6620334. DOI: 10.1038/s41598-019-46418-y.


Endocrine and exocrine pancreatic insufficiency after acute pancreatitis: long-term follow-up study.

Tu J, Zhang J, Ke L, Yang Y, Yang Q, Lu G BMC Gastroenterol. 2017; 17(1):114.

PMID: 29078749 PMC: 5658961. DOI: 10.1186/s12876-017-0663-0.


Suppression of Extrapancreatic Glucagon by Octreotide May Reduce the Fasting and Postprandial Glucose Levels in a Diabetic Patient after Total Pancreatectomy.

Okuma H, Bouchi R, Masuda S, Takeuchi T, Murakami M, Minami I Intern Med. 2017; 56(22):3061-3066.

PMID: 28943578 PMC: 5725861. DOI: 10.2169/internalmedicine.8963-17.